25 |
2022 IVRA International Medical Conference held successfully
2024-03-14
34
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-14 |
34 |
23 |
‘K-Medical Device’ winning 1st place in Malaysian Oncology Society paper
2024-03-29
33
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-29 |
33 |
22 |
World's first joint collaboration to overcome COVID-19 treatment, IVRA is launched.
2024-03-12
32
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
32 |
21 |
“Angola, no exception to the COVID-19 threat, recognizes the value of REMISSION 1℃”
2024-03-12
31
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
31 |
20 |
AdipoLABs signs research MOU with University of Cyber Jaya, Malaysia
2024-03-28
31
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-28 |
31 |
19 |
AdipoLABs’ ‘REMISSION 1℃’ cancer treatment effect recognized internationally
2024-03-29
30
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-29 |
30 |
17 |
AdipoLABs CEO Han Sung-ho visits the National Cemetery
2024-03-12
28
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
28 |
16 |
Presentng a new direction for COVID-19 and cancer treatment
2024-03-12
28
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
28 |
15 |
AdipoLABs signs research MOU with University of Cyber Jaya, Malaysia
2024-03-28
28
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-28 |
28 |
14 |
AdipoLABs launches ‘high-frequency hyperthermia cancer treatment device’ in Malaysia
2024-03-29
28
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-29 |
28 |
13 |
“COVID-19 treatment needs a major shift to hyperthermia therapy.”
2024-03-12
26
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
26 |